For investors in gene therapy biotech bluebird bio, a wait-and-see approach toward a proposed acquisition has paid off. | For ...

(Reuters) -Bluebird bio and Carlyle Group and SK Capital Partners said on Wednesday that the private equity firms have ...

Orchestra BioMed's AVIM earns FDA breakthrough designation, sparking investor optimism. Click here to read why OBIO stock is ...